Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - Pilot Study IM1.
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2013
At a glance
- Drugs Keyhole limpet haemocyanin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Mar 2012 Planned number of patients changed from 15 to 45 as reported by European Clinical Trials Database.
- 20 Mar 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2011-004394-90)